How Wu was paid
$3.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Yang WuChairman and Chief Executive Officer | $573,409 | $3,099,998 | — | $101,903 | — | $3,775,310 |
| Rodney WorthenChief Financial Officer | $204,685 | $43,350 | — | $21,642 | — | $269,677 |
| Isida TushePresident, General Counsel and Company Secretary | $450,000 | $715,000 | — | $46,508 | — | $1,211,508 |
| Dr. Shengxian WuChief Operating Officer | $400,000 | $715,000 | — | $41,340 | — | $1,156,340 |
| Dr. Wenjuan MattisChief Technology Officer | $400,000 | $543,000 | — | $41,340 | — | $984,340 |
| Carl T. SchultzFormer Chief Financial Officer | $122,818 | $365,750 | $1,071,000 | — | — | $1,559,568 |
| Fariyal KhanbabiFormer Chief Financial Officer | $118,113 | — | — | — | $200,000 | $318,113 |
What changed and why
- $3.8M$3,775,310 was CEO total compensation in 2025 versus $1,141,226 in 2024.
- $3.1M$3,099,998 of the CEO’s 2025 compensation consisted of stock awards.
- 85%85% of base salary was Yang Wu’s 2025 short-term incentive target.
- 50%50% of base salary was the 2025 incentive target for Isida Tushe and Dr. Shengxian Wu.
- $1.1M$1,071,000 was the grant-date fair value of Carl Schultz’s 2025 option award.
- $200K$200,000 of Fariyal Khanbabi’s compensation represented cash severance.
Other Microvast Holdings proxy statements
- 2025 proxy statement
Yang Wu paid $1.2M (+78% on the year).
Filed Sep 10, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.